U.S. Markets close in 5 hrs 18 mins

GlaxoSmithKline plc (GSK)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
44.08+0.46 (+1.05%)
As of 10:41AM EDT. Market open.
People also watch
Full screen
Previous Close43.62
Bid44.10 x 500
Ask44.11 x 1600
Day's Range43.89 - 44.14
52 Week Range37.20 - 45.58
Avg. Volume2,988,414
Market Cap106.9B
PE Ratio (TTM)50.43
Earnings DateN/A
Dividend & Yield1.95 (4.50%)
Ex-Dividend Date2017-05-10
1y Target EstN/A
Trade prices are not sourced from all markets
  • CNBC3 hours ago

    Early movers: ORCL, HAIN, ACN, SCS, ATUS, NVS, GSK & more

    These are the stocks posting the largest moves before the bell.

  • Reuters16 hours ago

    GSK wins $235 million from Teva in Coreg patent trial

    A U.S. jury has ordered Teva Pharmaceutical Industries Ltd to pay GlaxoSmithKline Plc more than $235 million for infringing a patent covering its blood pressure drug Coreg, court documents showed. A federal jury in Wilmington, Delaware on Tuesday found that Teva willfully infringed the patent in connection with its sales of a generic version of the drug with a label indicating it could be used for treating chronic heart failure. The jury rejected Teva's contention that the patent was invalid.

  • Forbes20 hours ago

    Amgen An Undervalued Industry Leader

    Given the company’s industry leading position, solid fundamentals and attractive stock valuation, we view it as a preferable alternative to traditional competitors in its industry.